Privately-held Ashvattha Therapeutics, a Californian firm advancing a new class of nanomedicine therapeutics that traverse ...

The European Commission (EC) has approved Danish CNS specialist Lundbeck (LUND: CO) and Otsuka Europe’s Rxulti ...

Insilico Medicine has raised $110 million in a series E funding round to drive the development of its artificial intelligence ...

US pharma giant Merck & Co (NYSE: MRK) has presented positive results from two pivotal Phase III trials of the ...

France-based Oncovita, a biotech specializing in vaccine development and a spin-off from the Institut Pasteur, and Unither ...

California-based Vivace Therapeutics has announced the closing of a $35 million Series D financing. The proceeds will support ...

Germany’s Heidelberg Pharma (FSE: HPHA) has modified its royalty financing agreement with HealthCare Royalty (HCRx), securing an additional $20 million upfront payment. The amendment extends the ...

PranaX, a Houston, USA-based biotech specializing in exosome-based regenerative therapies, has appointed Phillip Maderia as ...

Harbour BioMed (HKEX: 02142), a global biopharmaceutical company specializing in novel antibody therapeutics for immunology ...

USA-based Emergent BioSolutions (NYSE: EBS) and Swiss vaccines firm Rocketvax have announced an agreement. One part of the ...

The study found that N6LS (VH3810109 or VH109), given every four months in combination with already marketed monthly ...

ViiV Healthcare has announced promising results from two Phase IIa studies of investigational antiretroviral therapies, VH184 ...